KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short term Debt (2016 - 2025)

Historic Short term Debt for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Eli Lilly's Short term Debt fell 2127.46% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 2127.46%. This contributed to the annual value of $5.1 billion for FY2024, which is 2588.75% down from last year.
  • Eli Lilly's Short term Debt amounted to $1.6 billion in Q3 2025, which was down 2127.46% from $5.7 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Short term Debt ranged from a high of $6.9 billion in Q4 2023 and a low of $3.1 million during Q1 2023
  • Its 5-year average for Short term Debt is $2.5 billion, with a median of $1.7 billion in 2022.
  • Per our database at Business Quant, Eli Lilly's Short term Debt plummeted by 9984.91% in 2021 and then surged by 5317419.35% in 2024.
  • Over the past 5 years, Eli Lilly's Short term Debt (Quarter) stood at $1.5 billion in 2021, then decreased by 2.42% to $1.5 billion in 2022, then skyrocketed by 359.96% to $6.9 billion in 2023, then decreased by 25.89% to $5.1 billion in 2024, then plummeted by 68.09% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $5.7 billion for Q2 2025, and $4.0 billion during Q1 2025.